2ml vial of tirzepatide Eli Lilly Launches Self-Pay Vials for Patients With Obesity Tirzepatide – 60 mg Vial

The Weight Loss Showdown: Semaglutide vs

Tell your provider if you have a history of pancreatitis, diabetic retinopathy (vision changes), hypoglycemia (low blood sugar), kidney problems, gallbladder disease, or an allergy to any active ingredients in the tirzepatide or semaglutide product

LillyDirect Self-Pay: The Manufacturer Cash Program Eli Lilly offers a direct-to-consumer self-pay program for Zepbound only

Individuals considering semaglutide should discuss their alcohol intake with their healthcare provider to ensure the safe and effective use of the medication

Patients filling through a telehealth platform should ask for the dispensing pharmacy name and verify state licensure on their state board of pharmacy website